Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transposable Elements and Human Diseases: Mechanisms and Implication in the Response to Environmental Pollutants. | Int J Mol Sci | 2022 | 35269693 | PubTator, text mining | PubMed |
| PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. | J Exp Med | 2022 | 35266960 | PubTator, text mining | PubMed |
| New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology. | Front Immunol | 2022 | 35265082 | PubTator, text mining | PubMed |
| Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications. | Stem Cell Res Ther | 2022 | 35255980 | PubTator, text mining | PubMed |
| A Neutrophil Extracellular Traps Signature Predicts the Clinical Outcomes and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. | Front Mol Biosci | 2022 | 35252353 | PubTator, text mining | PubMed |
| Supported Lipid Bilayers and the Study of Two-Dimensional Binding Kinetics. | Front Mol Biosci | 2022 | 35252352 | PubTator, text mining | PubMed |
| Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer. | Front Oncol | 2022 | 35251966 | PubTator, text mining | PubMed |
| The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: "hexagonal pattern": a single-center retrospective study. | BMC Pulm Med | 2022 | 35246090 | PubTator, text mining | PubMed |
| Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT. | Blood Adv | 2022 | 35244681 | PubTator, text mining | PubMed |
| OIP5 Is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates. | Front Immunol | 2022 | 35242130 | PubTator, text mining | PubMed |
| Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma. | BMC Cancer | 2022 | 35241019 | PubTator, text mining | PubMed |
| Confusion, Hallucinations, and Primary Polydipsia: A Rare Presentation of Neurosarcoidosis. | Cureus | 2022 | 35237482 | PubTator, text mining | PubMed |
| Identification of a Novel Immune-Related lncRNA CTD-2288O8.1 Regulating Cisplatin Resistance in Ovarian Cancer Based on Integrated Analysis. | Front Genet | 2022 | 35237300 | PubTator, text mining | PubMed |
| ATP citrate lyase controls hematopoietic stem cell fate and supports bone marrow regeneration. | EMBO J | 2022 | 35229328 | PubTator, text mining | PubMed |
| Current Status and Prospects of Anesthesia and Breast Cancer: Does Anesthetic Technique Affect Recurrence and Survival Rates in Breast Cancer Surgery? | Front Oncol | 2022 | 35223475 | PubTator, text mining | PubMed |
| Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line. | Front Immunol | 2022 | 35222407 | PubTator, text mining | PubMed |
| Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing. | Front Immunol | 2022 | 35222382 | PubTator, text mining | PubMed |
| Oncogenes and the Origins of Leukemias. | Int J Mol Sci | 2022 | 35216407 | PubTator, text mining | PubMed |
| Anticancer Activities of Mushrooms: A Neglected Source for Drug Discovery. | Pharmaceuticals (Basel) | 2022 | 35215289 | PubTator, text mining | PubMed |
| Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma. | Front Oncol | 2022 | 35211406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=51